Home  >  News
Eppen_CellXpert_Mar2026
you can get e-magazine links on WhatsApp. Click here
News
  US FDA accepts Sun Pharma’s sBLA for Ilumya to treat adults with active psoriatic arthritis,   March 17, 2026
  Shilpa Biologicals and mAbTree Biologics secure US FDA orphan drug designation for breakthrough biologics to treat rare blood cancers,   March 13, 2026
  Aster DM Healthcare receives positive shareholder and creditors vote for Aster-QCIL merger,   March 13, 2026
  Bharat Parenterals enhances production efficiency with AI visual inspection technology from Xin Weisheng,   March 11, 2026
  BPL Med Tech acquires South Korea’s Yozma BMtech, expands preventive diagnostics and bone health portfolio,   March 11, 2026
  Anuh Pharma’s manufacturing facility found compliant during EDQM regulatory audit,   March 11, 2026
  Merck engages Young Minds at IISc Open Day 2026 with Interactive Science Activities,   March 10, 2026
  Archimedis Digital report highlights AI-led automation takes centre stage in pharma,   March 05, 2026
  Avio inks shareholders deal with Huwel; Targets large-scale public TB diagnostics opportunity,   March 02, 2026
  MedGenome makes a majority investment in Medcare Diagnostics to expand offerings across western India,   March 02, 2026
  Merck recognised as a Great Place To Work, sets a benchmark for workplace excellence,   March 02, 2026
  Zydus receives US FDA final approval for ivermectin tablets USP, 3 mg and Dapsone tablets USP, 25 mg & 100 mg,   March 02, 2026
  KITES Senior Care to invest Rs. 40 crore to double its specialised elder-care capacity by March 2027,   March 02, 2026
  Lupin receives EIR from US FDA for its Goa facility,   February 27, 2026
  Lupin Ranks No. 1 globally in pharma; Tops all sectors in India in S&P ESG Assessment 2025,   February 27, 2026
  Wellness company Wholeleaf secures Rs. 1.5 crore in seed funding round,   February 26, 2026
  Alembic Pharma receives US FDA approval for lamotrigine orally disintegrating tablets USP, 25 mg, 50 mg, 100 mg & 200 mg,   February 26, 2026
  Lupin receives US FDA approval for brivaracetam oral solution,   February 25, 2026
  Everstone Capital backed Integris Medtech gets SEBI nod for IPO,   February 25, 2026
  Biocon obtains approval for weight management drug, Liraglutide in the United States,   February 25, 2026

 Back
 
Propak_Asia_2026
CP_CPHI_Korea2026
IWE_CP_2026
ChemExpo_India_2026
PharmaTech_expo_Chandigarh2026
ASIA_PHARMA_EXPO_2026
CPHI_Japan26
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram